EVALUATING EOSINOPHILS AS PHARMACODYNAMIC BIOMARKERS OF MEPOLIZUMAB AND RESLIZUMAB FOR PATIENTS WITH EOSINOPHILIC ASTHMA.

被引：0
|
作者：
Gershuny, V. [1 ]
Florian, J. [1 ]
Wang, Y. [1 ]
Strauss, D. [1 ]
机构：
[1] US FDA, Silver Spring, MD USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2021年 / 109卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PIV-003
引用
收藏
页码：S62 / S62
页数：1
相关论文
共 50 条
  • [1] Real-world safety of treatment with mepolizumab and reslizumab in patients with severe eosinophilic asthma
    Ordonez Pinilla, Karen A.
    Moya Camacho, Beatriz
    Fernandez Rodriguez, Consuelo
    Fernandez Crespo, Jesus F.
    Garcia Moguel, Ismael
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2019, 143 (02) : AB99 - AB99
  • [2] Long-term effectiveness of Mepolizumab in patients with refractory severe eosinophilic asthma.
    Munoz Sanchez, Belen
    Alvarez Gutierrez, Francisco Javier
    Medina Gallardo, Juan Francisco
    Romero Falcon, Auxiliadora
    Maestre Sanchez, Maria Victoria
    Bastero Fernandez, Ana Gomez
    Cimbollek, Stefan
    Delgado Romero, Julio
    Ruiz Bernal, Ana
    Ferrer Galvan, Marta
    Garcia Garcia, Victor
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [3] Clinical and economic comparison of utilization of reslizumab, mepolizumab and benralizumab in the treatment of severe eosinophilic asthma
    Zyryanov, S. K.
    Avdeev, S. N.
    Ivanov, D. A.
    Zhuravleva, M., V
    Kniajeskaia, N. P.
    Matveev, N., V
    Nenasheva, N. A.
    Fomina, D. S.
    Frolov, M. Iu
    TERAPEVTICHESKII ARKHIV, 2020, 92 (12) : 172 - 179
  • [4] Mepolizumab alters the phenotype and activation status of peripheral blood eosinophils in patients with severe eosinophilic asthma
    Miguens-Suarez, Pablo
    Vazquez-Mera, Sara
    Martelo-Vidal, Laura
    Calvo-Alvarez, Uxio
    Ruiz-Ferreras, Raquel
    Blanco-Aparicio, Marina
    Gonzalez-Fernandez, Coral
    Mosteiro-Anon, Mar
    Dolores Corbacho-Abelaira, Maria
    Mendez-Brea, Paula
    Jose Nieto-Fontarigo, Juan
    Javier Salgado, Francisco
    Javier Gonzalez-Barcala, Francisco
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [5] Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma
    Agache, Ioana
    Beltran, Jessica
    Akdis, Cezmi
    Akdis, Mubeccel
    Canelo-Aybar, Carlos
    Canonica, Giorgio Walter
    Casale, Thomas
    Chivato, Tomas
    Corren, Jonathan
    Del Giacco, Stefano
    Eiwegger, Thomas
    Firinu, Davide
    Gern, James E.
    Hamelmann, Eckard
    Hanania, Nicola
    Makela, Mika
    Martin, Irene Hernandez
    Nair, Parameswaran
    O'Mahony, Liam
    Papadopoulos, Nikolaos G.
    Papi, Alberto
    Park, Hae-Sim
    Perez de Llano, Luis
    Posso, Margarita
    Rocha, Claudio
    Quirce, Santiago
    Sastre, Joaquin
    Shamji, Mohamed
    Song, Yang
    Steiner, Corinna
    Schwarze, Jurgen
    Alonso-Coello, Pablo
    Palomares, Oscar
    Jutel, Marek
    ALLERGY, 2020, 75 (05) : 1023 - 1042
  • [6] Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma
    Ortega, Hector G.
    Liu, Mark C.
    Pavord, Ian D.
    Brusselle, Guy G.
    FitzGerald, J. Mark
    Chetta, Alfredo
    Humbert, Marc
    Katz, Lynn E.
    Keene, Oliver N.
    Yancey, Steven W.
    Chanez, Pascal
    NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (13): : 1198 - 1207
  • [7] RESPONSE TO RESLIZUMAB IN SEVERE ASTHMA PATIENTS UNRESPONSIVE TO MEPOLIZUMAB OR WITH SUSPECTED VASCULITIS
    Hama, B.
    Thomas, N.
    Elsey, L.
    Hince, K.
    Waye, R.
    Allen, D.
    Holmes, L.
    Pantin, T.
    Tavernier, G.
    Fowler, S.
    Niven, R.
    THORAX, 2019, 74 : A140 - A140
  • [8] Asthma Control In Patients With Severe Eosinophilic Asthma Treated With Mepolizumab
    Llanos-Ackert, J. -P.
    Price, R. G.
    Forshag, M.
    Yancey, S.
    Liu, M. C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [9] Impact of Reslizumab on Duration of Exacerbations in Patients with Severe Eosinophilic Asthma
    Manning, Michael E.
    Garin, Margaret
    Jiang, Bo
    Sun, Shawn X.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2018, 141 (02) : AB17 - AB17
  • [10] Efficacy and safety of reslizumab in patients with moderate to severe eosinophilic asthma
    Lim, Hui Fang
    Nair, Parameswaran
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2015, 9 (02) : 135 - 142
12345